BTI
CYTK icon

Blue Trust Inc’s Cytokinetics CYTK Stock Holding History

Blue Trust Inc’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$198 – 2486
2026
Q1 		$198 Buy
+3
New +$191 ﹤0.01% 2411
2025
Q4 		– Sell
-5
Closed -$275 – 2570
2025
Q3 		$275 Hold
5
– – ﹤0.01% 2492
2025
Q2 		$165 Sell
5
-211
-98% -$7.34K ﹤0.01% 2390
2025
Q1 		$8.68K Hold
216
– – ﹤0.01% 1951
2024
Q4 		$10.2K Sell
216
-765
-78% -$39.7K ﹤0.01% 1846
2024
Q3 		$53.2K Buy
981
+680
+226% +$37.9K ﹤0.01% 1538
2024
Q2 		$21.1K Buy
+301
New +$18.2K ﹤0.01% 1636
2023
Q2 		– Sell
-12
Closed -$1K – 2113
2023
Q1 		$1K Buy
+12
New +$490 ﹤0.01% 2131

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Trust Inc's CYTK Position: Q2 2026 in Review

Blue Trust Inc sold out of Cytokinetics (CYTK) in Q2 2026, closing a stake of 3 shares — an estimated $198 sold.

Blue Trust Inc first reported a position in CYTK in Q1 2023 and held it in 8 quarters. The position peaked at $53.2K in Q3 2024. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Blue Trust Inc reported no remaining Cytokinetics position as of Q2 2026 after selling out during the quarter.
  • Blue Trust Inc sold 3 Cytokinetics shares in Q2 2026, an estimated $198.
  • Blue Trust Inc first reported a position in Cytokinetics in Q1 2023 and held it in 8 quarters.
  • Blue Trust Inc's Cytokinetics position peaked at $53.2K in Q3 2024.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.